APPLIN: After nearly 20 years in HIV care, I’ve seen that HIV follows people through every season of life. When life is stable, patients stay in care and maintain suppression, but when challenges ...
In these uncertain, volatile, and unprecedented times, the role of science is more important than ever. Scientific advances that benefit humanity and ensure planetary sustainability for current and ...
Yeztugo (lenacapavir) is more than 99.9 percent effective at protecting at-risk people from HIV — but for many, accessing the drug may be a challenge. Yeztugo (lenacapavir) is the first and only ...
The Gauteng Department of Health has strengthened its STI prevention strategy through targeted screening, outreach, and HIV ...
SEATTLE, WA -- For the first time, a study shows that a drug used to treat HIV infection also can help prevent it when taken before and after risky sex by gay men. The results offer hope of a more ...
Gilead has developed a 1-every-6-month injection to prevent HIV. The medication will sell for $14,000 a shot. With numerous proposed major cuts to Medicaid and the Affordable Care Act in congress, ...
A growing coalition of HIV prevention organizations, health experts and Democrats in Congress are sounding the alarm over sweeping Trump administration cuts to HIV/AIDS prevention and surveillance ...
Approved in the US as the world’s first twice-yearly HIV prevention shot, lenacapavir is now set to be made in India at a ...
A new set of initiatives, funded under the EU4Health 2024 Work Programme, has begun, continuing to support Europe’s Beating ...
Malawi breaking news publishing 24 hours a day news about Malawi, Malawi Business, Malawi Tourism, Malawi Politics, Malawi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results